General Anesthesia Articles & Analysis
17 news found
Cardiac arrest: Anesthesia has been proven to be a contributing factor, or even a leading cause, in cardiac arrest, a small percentage of the time. ...
Having established close cooperative relations with many pharmaceutical companies, universities, and research institutions, Alfa Chemistry decided to enlarge its active pharmaceutical ingredient (API) supply continuously in the hope of providing a more diversified product portfolio for customers. Fairly recently, the company announced the launch of dexmedetomidine hydrochloride, another API ...
The entire body does not need to be shut down (general anesthesia) in order for one area to be worked on without pain, in many cases. ...
No identifiable prior medical treatment; Impossibility for the patient to participate in prolonged medical follow-up; Unstable psychotic disorders, severe depressive syndromes that have not been stabilized with a specific treatment, suicidal tendencies; Alcoholism or drug addiction; Severe eating disorders (such as bulimia); An insufficient mastication coefficient; Documented ...
EvoEndo® was founded by clinicians to address the significant need to reduce the use of general anesthesia and sedation during endoscopic procedures in pediatric and adult patients. ...
ByEvoEndo
EvoEndo’s Single-Use Endoscopy System or the “EvoEndo System” eliminates the need for general anesthesia or conscious sedation during routine upper endoscopic procedures The EvoEndo System is being distributed by Micro-Tech Endoscopy USA with commercial sales slated to begin following completion of first clinical cases at several pediatric ...
ByEvoEndo
EvoEndo’s system combines a sterile, single-use, flexible, ultra-slim gastroscope with virtual reality (VR) patient entertainment to allow the procedure to be performed safely in children and adults without anesthesia or sedation. EvoEndo’s system is currently pending US FDA 510(k) clearance and not available for sale in the U.S. Heather Underwood, Chief Executive ...
ByEvoEndo
EvoEndo’s mission is to make endoscopies safer for patients by eliminating the need for general anesthesia while reducing the complexity and cost of endoscopy for physicians and hospitals. EvoEndo’s system combines sterile, single-use, flexible endoscopes with VR-based patient distraction to allow the procedure to be performed safely in children and ...
ByEvoEndo
For years, if doctors couldn’t bring the swelling down in your sinuses and clear the nasal passages with medication alone, they would have to go in and operate under general anesthesia. Over time, doctors developed less invasive techniques including a way to expand and clear the nasal passages endoscopically. ...
Current treatment options, such as sacral nerve stimulation devices, require extensive surgery, general anesthesia and battery replacement. Other treatments require weekly visits to the doctor’s office. ...
Current treatment options, such as sacral nerve stimulation devices, require extensive surgery, general anesthesia and battery replacement. RENOVA is a tiny, battery-less and lead-less neurostimulation implant that provides a patient-centric, home-based alternative therapy option for women with OAB. ...
A large complex sigmoid polyp in a 62-year-old male patient was successfully removed in a 60-minute procedure without surgical intervention using DiLumen C2, a second-generation endoscopic dual balloon colon stabilization accessory that employs two 6mm working channels that accommodate several flexible therapeutic instruments designed to efficiently retract and dissect tissue. ...
AventaMed, a Cork-based medical device start-up which is set to revolutionise paediatric ear, nose and throat surgery has beaten 26 global organizations in a major medical device bid. The pioneering company will be one of 12 Real-World Evidence Test-Cases selected by The National Evaluation System for Health Technology Coordinating Center (NESTcc) to evaluate the use of real-world evidence (RWE) ...
Uses of the Propofusor include the induction and maintenance of general anesthesia, sedation of mechanically ventilated adults in intensive care, and conscious sedation during diagnostic and surgical procedures. With an estimated 2.5 million surgical and 1.2 million gastrointestinal procedures annually, the market opportunity for anesthesia ...
Mercury Biomed, a company developing a novel approach to managing core body temperature, was awarded a $1.5 million non-dilutive Phase II Small Business Technology Transfer (STTR) grant through the National Institute of General Medical Sciences (NIGMS). The award (2 R42 GM119871-02) will enable Mercury to continue along the path toward commercialization of its first device, ...
Adipocell is USRM’s proprietary, stem cell kit that enables physicians to separate potent stem cells from a patient’s own fat cells, which are harvested and reinserted in a two-hour procedure that is generally minimally invasive and does not require general anesthesia. Using one’s own stem cells may be a significant advantage, ...
Mercury Biomed, a company developing a novel approach to managing core body temperature, announces it has won a non-dilutive Phase I Small Business Technology Transfer (STTR) grant through the National Institute of General Medical Sciences (NIGMS) for $225,000. The award (R41GM119871) will enable Mercury to accelerate commercialization of its first device, a disruptive solution ...